Keyphrases
Chronic Granulomatous Disease
100%
Chronic Osteomyelitis
100%
Thalidomide
100%
Inflammatory Complications
40%
Infectious Osteomyelitis
40%
Therapeutic Potential
20%
Hyperinflammation
20%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
20%
T Helper 17 (Th17)
20%
Toll-like
20%
Copyright
20%
No-report
20%
Receptor Activation
20%
Differential Diagnosis
20%
Clinical Response
20%
Patient Selection
20%
Inflammatory Markers
20%
No Adverse Effect
20%
Primary Immunodeficiency
20%
Safety Profile
20%
Corticosteroids
20%
Clinical Resolution
20%
Infectious Complications
20%
Nuclear Factor Erythroid 2-related Factor 2 (Nrf2)
20%
Inflammatory Parameters
20%
Recurrent Infection
20%
Thigh
20%
Inflammasome Activation
20%
Acute Phase Reactants
20%
Microbiological Test
20%
Neutrophil Apoptosis
20%
American Academy of Pediatrics
20%
Bone Biopsy
20%
Radiologic Resolution
20%
Symptom Parameter
20%
Bone Involvement
20%
Difficulty Walking
20%
Inflammatory Manifestations
20%
Bone Scintigraphy
20%
Broad-spectrum Antibiotic Therapy
20%
Medicine and Dentistry
Osteomyelitis
100%
Thalidomide
100%
Chronic Granulomatous Disease
100%
Programmed Cell Death
20%
Adverse Event
20%
Differential Diagnosis
20%
Nonsteroid Antiinflammatory Agent
20%
Walking Difficulty
20%
Thigh
20%
Antibiotic Therapy
20%
Broad-Spectrum Antibiotic
20%
Immune Deficiency
20%
Toll Like Receptor
20%
Transcription Factor Nrf2
20%
Recurrent Infection
20%
Bone Scintigraphy
20%
Back
20%
Bone Biopsy
20%
Th17 Cell
20%
Pediatrics
20%
Neutrophil
20%
Inflammasome
20%
Acute Phase Protein
20%
Immunology and Microbiology
Chronic Granulomatous Disease
100%
Thalidomide
100%
Immunodeficiency
20%
Toll-Like Receptor
20%
Acute Phase Protein
20%
Neutrophil
20%
Th17 Cell
20%
Back
20%
Inflammasome
20%
Transcription Factor Nrf2
20%